T1	Qualitative_Concept 7 11	last
T2	Quantitative_Concept 12 21	decades ,
T3	Quantitative_Concept 22 28	number
T4	Therapeutic_or_Preventive_Procedure 32 37	drugs
T5	Pharmacologic_Substance 32 37	drugs
T6	Finding 43 52	withdrawn
T7	Intellectual_Product 43 52	withdrawn
T8	Mental_or_Behavioral_Dysfunction 43 52	withdrawn
T9	Activity 43 52	withdrawn
T10	Functional_Concept 53 59	due to
T11	Functional_Concept 60 65	cases
T12	Quantitative_Concept 60 65	cases
T13	Functional_Concept 75 82	leading
T14	Temporal_Concept 75 82	leading
T15	Geographic_Area 83 85	to
T16	Enzyme 83 85	to
T17	Qualitative_Concept 83 85	to
T18	Amino_Acid__Peptide__or_Protein 83 85	to
T19	Research_Activity 96 114	assessment of drug
T20	Clinical_Attribute 115 128	QT interval .
T21	Clinical_Attribute 115 128	QT interval .
T22	Functional_Concept 136 142	case ,
T23	Medical_Device 136 142	case ,
T24	Conceptual_Entity 136 142	case ,
T25	Pharmacologic_Substance 143 154	hydroxyzine
T26	Organic_Chemical 143 154	hydroxyzine
T27	Laboratory_or_Test_Result 159 186	identified as the only drug
T28	Quantitative_Concept 177 181	only
T29	Intellectual_Product 177 181	only
T30	Finding 187 191	able
T31	Organism_Attribute 187 191	able
T32	Geographic_Area 192 194	to
T33	Enzyme 192 194	to
T34	Qualitative_Concept 192 194	to
T35	Amino_Acid__Peptide__or_Protein 192 194	to
T36	Functional_Concept 195 201	induce
T37	Finding 202 227	QTc interval prolongation
T38	Pathologic_Function 202 227	QTc interval prolongation
T39	Patient_or_Disabled_Group 235 243	patients
T40	Functional_Concept 244 250	active
T41	Idea_or_Concept 244 250	active
T42	Qualitative_Concept 244 250	active
T43	Functional_Concept 251 263	medication .
T44	Pharmacologic_Substance 251 263	medication .
T45	Injury_or_Poisoning 277 297	hydroxyzine overdose
T46	Finding 302 310	detected
T47	Therapeutic_or_Preventive_Procedure 302 310	detected
T48	Idea_or_Concept 311 319	probably
T49	Functional_Concept 320 326	due to
T50	Quantitative_Concept 327 342	high posology ,
T51	Disease_or_Syndrome 343 367	bile ducts obstruction ,
T52	Disease_or_Syndrome 372 388	liver impairment
T53	Enzyme 399 404	GPT )
T54	Amino_Acid__Peptide__or_Protein 399 404	GPT )
T55	Pharmacologic_Substance 407 417	Cetirizine
T56	Organic_Chemical 407 417	Cetirizine
T57	Pharmacologic_Substance 425 437	hydroxyzines
T58	Organic_Chemical 425 437	hydroxyzines
T59	Qualitative_Concept 438 443	major
T60	Functional_Concept 444 450	active
T61	Idea_or_Concept 444 450	active
T62	Qualitative_Concept 444 450	active
T63	Biologically_Active_Substance 451 463	metabolite ;
T64	Tissue 484 489	blood
T65	Body_Substance 484 489	blood
T66	Geographic_Area 490 495	level
T67	Qualitative_Concept 490 495	level
T68	Pharmacologic_Substance 490 495	level
T69	Classification 490 495	level
T70	Quantitative_Concept 496 502	dosage
T71	Functional_Concept 507 510	not
T72	Functional_Concept 511 522	performed .
T73	Physical_Object 539 550	combination
T74	Finding 539 550	combination
T75	Qualitative_Concept 539 550	combination
T76	Injury_or_Poisoning 554 574	hydroxyzine overdose
T77	Population_Group 579 588	transient
T78	Temporal_Concept 579 588	transient
T79	Pathologic_Function 589 602	renal failure
T80	Disease_or_Syndrome 589 602	renal failure
T81	Functional_Concept 614 618	lead
T82	Therapeutic_or_Preventive_Procedure 614 618	lead
T83	Hazardous_or_Poisonous_Substance 614 618	lead
T84	Inorganic_Chemical 614 618	lead
T85	Pharmacologic_Substance 614 618	lead
T86	Element__Ion__or_Isotope 614 618	lead
T87	Geographic_Area 619 621	to
T88	Enzyme 619 621	to
T89	Qualitative_Concept 619 621	to
T90	Amino_Acid__Peptide__or_Protein 619 621	to
T91	Pharmacologic_Substance 622 632	cetirizine
T92	Organic_Chemical 622 632	cetirizine
T93	Finding 633 647	accumulation .
T94	Pharmacologic_Substance 658 668	cetirizine
T95	Organic_Chemical 658 668	cetirizine
T96	Geographic_Area 675 677	to
T97	Enzyme 675 677	to
T98	Qualitative_Concept 675 677	to
T99	Amino_Acid__Peptide__or_Protein 675 677	to
T100	Organ_or_Tissue_Function 696 724	ventricular repolarization ,
T101	Quantitative_Concept 750 756	dose .
T102	Clinical_Attribute 750 756	dose .
T103	Quantitative_Concept 764 768	only
T104	Intellectual_Product 764 768	only
T105	Quantitative_Concept 769 772	one
T106	Intellectual_Product 773 782	published
T107	Occupational_Activity 773 782	published
T108	Professional_or_Occupational_Group 783 791	clinical
T109	Qualitative_Concept 783 791	clinical
T110	Functional_Concept 792 796	case
T111	Medical_Device 792 796	case
T112	Conceptual_Entity 792 796	case
T113	Pharmacologic_Substance 800 819	hydroxyzine-induced
T114	Organic_Chemical 800 819	hydroxyzine-induced
T115	Functional_Concept 800 819	hydroxyzine-induced
T116	Finding 820 837	QT prolongation .
T117	Functional_Concept 843 847	case
T118	Medical_Device 843 847	case
T119	Conceptual_Entity 843 847	case
T120	Temporal_Concept 858 867	recurrent
T121	Amphibian 868 875	syncope
T122	Sign_or_Symptom 868 875	syncope
T123	Pharmacologic_Substance 883 894	hydroxyzine
T124	Organic_Chemical 883 894	hydroxyzine
T125	Functional_Concept 895 904	treatment
T126	Research_Activity 895 904	treatment
T127	Therapeutic_or_Preventive_Procedure 895 904	treatment
T128	Conceptual_Entity 895 904	treatment
T129	Health_Care_Activity 895 904	treatment
T130	Qualitative_Concept 908 913	usual
T131	Quantitative_Concept 914 922	posology
T132	Quantitative_Concept 914 922	posology
T133	Clinical_Attribute 914 922	posology
T134	Temporal_Concept 928 939	34-year-old
T135	Temporal_Concept 928 939	34-year-old
T136	Population_Group 940 945	woman
T137	Idea_or_Concept 946 956	presenting
T138	Gene_or_Genome 959 963	hERG
T139	Genetic_Function 964 974	mutation .
T140	Cell_or_Molecular_Dysfunction 964 974	mutation .
T141	Gene_or_Genome 975 979	hERG
T142	Gene_or_Genome 980 984	gene
T143	Intellectual_Product 985 990	codes
T144	Occupational_Activity 985 990	codes
T145	Classification 985 990	codes
T146	Quantitative_Concept 999 1006	subunit
T147	Amino_Acid__Peptide__or_Protein 999 1006	subunit
T148	Amino_Acid__Peptide__or_Protein 1012 1029	potassium channel
T149	Biologically_Active_Substance 1012 1029	potassium channel
T150	Inorganic_Chemical 1032 1033	I
T151	Amino_Acid__Peptide__or_Protein 1032 1033	I
T152	Immunologic_Factor 1032 1033	I
T153	Geographic_Area 1034 1036	Kr
T154	Organ_or_Tissue_Function 1057 1085	ventricular repolarization .
T155	Animal 1110 1115	shown
T156	Pharmacologic_Substance 1121 1132	hydroxyzine
T157	Organic_Chemical 1121 1132	hydroxyzine
T158	Functional_Concept 1159 1167	blocking
T159	Mental_or_Behavioral_Dysfunction 1159 1167	blocking
T160	Gene_or_Genome 1168 1172	hERG
T161	Conceptual_Entity 1173 1181	channels
T162	Spatial_Concept 1173 1181	channels
T163	Cell_Function 1207 1223	action potential
T164	Pharmacologic_Substance 1224 1234	duration ,
T165	Temporal_Concept 1224 1234	duration ,
T166	Functional_Concept 1240 1248	inducing
T167	Quantitative_Concept 1262 1268	French
T168	Population_Group 1262 1268	French
T169	Language 1262 1268	French
T170	Research_Activity 1269 1286	pharmacovigilance
T171	Intellectual_Product 1287 1297	database ,
T172	Intellectual_Product 1287 1297	database ,
T173	Quantitative_Concept 1301 1306	found
T174	Functional_Concept 1310 1315	cases
T175	Quantitative_Concept 1310 1315	cases
T176	Finding 1319 1334	QT prolongation
T177	Pharmacologic_Substance 1346 1357	hydroxyzine
T178	Organic_Chemical 1346 1357	hydroxyzine
T179	Idea_or_Concept 1365 1374	suspected
T180	Qualitative_Concept 1365 1374	suspected
T181	Idea_or_Concept 1375 1389	accountability
T182	Intellectual_Product 1390 1397	assumed
T183	Occupational_Activity 1414 1421	publish
T184	Quantitative_Concept 1431 1436	first
T185	Qualitative_Concept 1431 1436	first
T186	Professional_or_Occupational_Group 1437 1445	clinical
T187	Qualitative_Concept 1437 1445	clinical
T188	Functional_Concept 1446 1450	case
T189	Medical_Device 1446 1450	case
T190	Conceptual_Entity 1446 1450	case
T191	Finding 1476 1491	QT prolongation
T192	Quantitative_Concept 1497 1508	drug dosage
T193	Medical_Device 1509 1515	data .
T194	Idea_or_Concept 1509 1515	data .
T195	Eukaryote 1509 1515	data .
T196	Mental_Process 1520 1531	association
T197	Phenomenon_or_Process 1520 1531	association
T198	Qualitative_Concept 1520 1531	association
T199	Social_Behavior 1520 1531	association
T200	Pharmacologic_Substance 1535 1548	hydroxyzine ,
T201	Organic_Chemical 1535 1548	hydroxyzine ,
T202	Quantitative_Concept 1563 1578	high posology ,
T203	Finding 1583 1589	others
T204	Pharmacologic_Substance 1583 1589	others
T205	Qualitative_Concept 1598 1608	well-known
T206	Manufactured_Object 1598 1608	well-known
T207	Qualitative_Concept 1598 1608	well-known
T208	Idea_or_Concept 1613 1618	risks
T209	Functional_Concept 1619 1626	factors
T210	Conceptual_Entity 1619 1626	factors
T211	Functional_Concept 1629 1638	including
T212	Finding 1639 1650	hypokalemia
T213	Finding 1655 1668	bradycardia )
T214	Pathologic_Function 1655 1668	bradycardia )
T215	Functional_Concept 1675 1681	induce
T216	Finding 1682 1697	QT prolongation
T217	Finding 1702 1717	lifethreatening
T218	Idea_or_Concept 1702 1717	lifethreatening
T219	Quantitative_Concept 1728 1735	present
T220	Idea_or_Concept 1728 1735	present
T221	Occupational_Activity 1736 1740	work
T222	Temporal_Concept 1756 1762	recent
T223	Functional_Concept 1763 1771	addition
T224	Pharmacologic_Substance 1775 1786	hydroxyzine
T225	Organic_Chemical 1775 1786	hydroxyzine
T226	Intellectual_Product 1794 1807	list of drugs
T227	Functional_Concept 1813 1824	conditional
T228	Qualitative_Concept 1813 1824	conditional
T229	Idea_or_Concept 1825 1829	risk
T230	Therapeutic_or_Preventive_Procedure 1841 1846	drugs
T231	Pharmacologic_Substance 1841 1846	drugs
T232	Geographic_Area 1847 1849	to
T233	Enzyme 1847 1849	to
T234	Qualitative_Concept 1847 1849	to
T235	Amino_Acid__Peptide__or_Protein 1847 1849	to
T236	Patient_or_Disabled_Group 1864 1872	patients
T237	Disease_or_Syndrome 1878 1907	congenital long QT syndrome .
T238	Therapeutic_or_Preventive_Procedure 1916 1923	reminds
T239	Idea_or_Concept 1929 1940	recommended
T240	Clinical_Attribute 1941 1962	hydroxyzines posology
T241	Social_Behavior 1971 1982	respected ,
T242	Idea_or_Concept 1987 1991	risk
T243	Finding 1995 2010	QT prolongation
T244	Amphibian 2015 2022	syncope
T245	Sign_or_Symptom 2015 2022	syncope
T246	Quantitative_Concept 2023 2032	increases
T247	Functional_Concept 2023 2032	increases
T248	Functional_Concept 2049 2053	case
T249	Medical_Device 2049 2053	case
T250	Conceptual_Entity 2049 2053	case
T251	Finding 2060 2070	overdose .
T252	Idea_or_Concept 2060 2070	overdose .
T253	Injury_or_Poisoning 2060 2070	overdose .
T254	Idea_or_Concept 2081 2092	considering
T255	Quantitative_Concept 2097 2102	large
T256	Functional_Concept 2103 2109	use of
T257	Substance 2114 2124	molecule ,
T258	Pathologic_Function 2129 2139	recurrence
T259	Neoplastic_Process 2129 2139	recurrence
T260	Phenomenon_or_Process 2129 2139	recurrence
T261	Pharmacologic_Substance 2143 2162	hydroxyzine-induced
T262	Organic_Chemical 2143 2162	hydroxyzine-induced
T263	Functional_Concept 2143 2162	hydroxyzine-induced
T264	Finding 2163 2178	QT prolongation
T265	Idea_or_Concept 2182 2190	probably
T266	Idea_or_Concept 2208 2219	Information
T267	Functional_Concept 2228 2233	given
T268	Idea_or_Concept 2228 2233	given
T269	Intellectual_Product 2228 2233	given
T270	Conceptual_Entity 2228 2233	given
T271	Professional_or_Occupational_Group 2237 2248	clinician .
